Laddar...
Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey
BACKGROUND: The Risk Evaluation and Mitigation Strategy (REMS) for retigabine/ezogabine (RTG/EZG) required an evaluation of the effectiveness of the communication plan to communicate about the risks with use of RTG/EZG. OBJECTIVE: GlaxoSmithKline conducted a survey to assess understanding of the ris...
Sparad:
| I publikationen: | Drugs Real World Outcomes |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674522/ https://ncbi.nlm.nih.gov/pubmed/26690543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-015-0042-5 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|